Why This Promising Drug Will Be Pfizer's Next Blockbuster

Why This Promising Drug Will Be Pfizer's Next Blockbuster

Source: 
Motley Fool
snippet: 
  • The medication could soon be approved to treat an addressable market of nearly 200,000 patients.
  • Etrasimod, intended to treat ulcerative colitis, could haul in $1 billion in annual sales for Pfizer.
  • The market is overly pessimistic about the eventual drop in Pfizer's coronavirus-related revenue